Table 1.
Characteristics of study participants.
| Characteristics at exacerbation | |
|---|---|
| Age (years) | 34.0 (22–52) |
| Gender (%female) | 57.9% |
| BMI (kg/m2) | 25.5 (19.1–39.5) |
| Blood eosinophils (x10ˆ/L) | 0.3 (0–1.2) |
| Peakflow % of pred. post beta2 – In the ED | 64.5 (±16.6) |
| Current smoker (%) | 26.3% |
| Former smoker (%) | 26.3% |
| Pack-years (20 cigarettes/day for a year) | 2.5 (0–40) |
| Daily ICS dose* (n = 7) | 800 (350–1440) |
| FEV1 (% of predicted) | 67.9 (±24.6) |
| FeNO > 25 ppb (%) | 73.7% |
| FeNO (ppb) | 34.0 (7–102) |
| 5-item ACQ score | 3.8 (0.2–5.4) |
| Sputum Eosinophils > 3% | 63.6% |
| Sputum Eosinophils (%) | 6.5 (0–36.5) |
ED: Emergency Department, ICS: Inhaled Corticosteroids, ppb: parts per billion, ACQ: asthma control questionnaire. * Budesonide equivalent dose.